APA (7th ed.) Citation

M, M., F, R., S, R., G, C., C, S., A, S., . . . M, C. (2024). Sustained antiviral response against in vitro HIV-1 infection in peripheral blood mononuclear cells from people with chronic myeloid leukemia treated with ponatinib. Frontiers in pharmacology, 15, 1426974. https://doi.org/10.3389/fphar.2024.1426974

Chicago Style (17th ed.) Citation

M, Manzanares, et al. "Sustained Antiviral Response Against in Vitro HIV-1 Infection in Peripheral Blood Mononuclear Cells from People with Chronic Myeloid Leukemia Treated with Ponatinib." Frontiers in Pharmacology 15 (2024): 1426974. https://doi.org/10.3389/fphar.2024.1426974.

MLA (9th ed.) Citation

M, Manzanares, et al. "Sustained Antiviral Response Against in Vitro HIV-1 Infection in Peripheral Blood Mononuclear Cells from People with Chronic Myeloid Leukemia Treated with Ponatinib." Frontiers in Pharmacology, vol. 15, 2024, p. 1426974, https://doi.org/10.3389/fphar.2024.1426974.